SARS-CoV-2 Recombinant Nucleocapsid Protein, aa1-419 (HEK293-expressed)

Novel coronavirus (SARS-CoV-2/ 2019-nCoV) nucleocapsid protein (recombinant), amino acids Met1-Ala419

SARS-CoV-2 Recombinant Nucleocapsid Protein, aa1-419 (HEK293-expressed)

Novel coronavirus (SARS-CoV-2/ 2019-nCoV) nucleocapsid protein (recombinant), amino acids Met1-Ala419

From: 1,244 USD
Catalog #
(Select a product)
Novel coronavirus (SARS-CoV-2/ 2019-nCoV) nucleocapsid protein (recombinant), amino acids Met1-Ala419
Add to Wish List

Overview

SARS-CoV-2 Recombinant Nucleocapsid Protein, aa1-419 is expressed in HEK293 cells and is one of four structural proteins encoded by the SARS-CoV-2 genome. The Nucleocapsid Protein is transcribed from the viral “N” gene and is the protein that interacts with RNA to form the nucleocapsid. The protein forms a homo-oligomer, and both the monomer and the oligomer can interact with RNA. This protein also interacts with the membrane protein (protein M) after infection of the host cell during packaging of the positive-strand viral genome RNA into the ribonucleocapsid during virion assembly.
Subtype
Recombinant Proteins
Alternative Names
Nucleocapsid protein, NC, Protein N, N, N Protein
Cell Type
B Cells, Lymphocytes, Plasma, T Cells, T Cells, CD4+, T Cells, CD8+
Species
Human
Area of Interest
Infectious Diseases
Purity
≥ 90%

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
100-0593, 100-0592
Lot #
All
Language
English
Document Type
Safety Data Sheet
Catalog #
100-0593, 100-0592
Lot #
All
Language
English